基因变化与皮肤状甲状腺癌的临床病理特征之间的相关性
Shixuan Shang1, Huimin Yang2, Meixiang Chen1
1Department of Pathology, The First People's Hospital of Jiangxia District (Union Jiangnan Hospital), Wuhan, China.
The Journal of international medical research
|March 8, 2024
概括
乳头甲状腺癌 (PTC) 的多基因变化与淋巴结转移和囊入侵相关. BRAF突变是关键指标,特别是在老年患者中,有助于PTC预后和管理.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 乳头甲状腺癌 (PTC) 是最常见的甲状腺恶性瘤.
- 了解PTC的遗传情景对于诊断和治疗至关重要.
- 临床病理特征显著影响PTC患者的治疗结果.
研究的目的:
- 探索多基因变异与PTC中的临床病理特征之间的关系.
- 为了确定与PTC进展和患者预后相关的特定基因突变.
- 在PTC中评估基因突变分析的诊断和预后价值.
主要方法:
- 对111个甲状腺结节细胞学标本 (74个PTC,37个良性) 的回顾性分析.
- 使用了22基因突变测定与下一代测序.
- 收集和分析临床病理学数据.
主要成果:
- 基因变化与增加的淋巴结转移 (LNM) 和囊入侵相关.
- 年龄较小 (<45岁) 与基因变异有关,是LNM的独立风险因素.
- BRAF突变在PTC和良性组之间显示出显著差异,并且与老年患者 (≥45岁) 的LNM有关.
结论:
- 多基因变化为PTC行为和进展提供了洞察力.
- BRAF突变测试对于预测PTC预后非常有价值,特别是在老年人中.
- 这些发现支持基于基因分析的增强PTC管理策略.
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K


